IVA
Twin Vee Powercats, Inc.
NASDAQ · Healthcare · Biotechnology · FR
$2.98
+1.36%Year over year
Reported trailing growth
- Revenue
- -87.8%
- EBITDA
- +47.7%
- EBIT
- -41.5%
- EPS
- +87.2%
- Free cash flow
- -23.9%
- Operating cash flow
- -23.7%
Forward estimates
Based on analyst estimates
- Revenue
- +1011.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -28.3%
- EBITDA
- +23.3%
- EBIT
- -34.2%
- Net income
- -84.7%
- EPS
- +48.6%
- Free cash flow
- -17.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026